These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 9151363

  • 1. Improvement in accuracy of delayed recall in aged and non-aged, mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418.
    Prendergast MA, Terry AV, Jackson WJ, Marsh KC, Decker MW, Arneric SP, Buccafusco JJ.
    Psychopharmacology (Berl); 1997 Apr; 130(3):276-84. PubMed ID: 9151363
    [Abstract] [Full Text] [Related]

  • 2. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement.
    Buccafusco JJ, Jackson WJ, Terry AV, Marsh KC, Decker MW, Arneric SP.
    Psychopharmacology (Berl); 1995 Aug; 120(3):256-66. PubMed ID: 8524972
    [Abstract] [Full Text] [Related]

  • 3. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys.
    Prendergast MA, Jackson WJ, Terry AV, Decker MW, Arneric SP, Buccafusco JJ.
    Psychopharmacology (Berl); 1998 Mar; 136(1):50-8. PubMed ID: 9537682
    [Abstract] [Full Text] [Related]

  • 4. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys.
    Buccafusco JJ, Terry AV, Decker MW, Gopalakrishnan M.
    Biochem Pharmacol; 2007 Oct 15; 74(8):1202-11. PubMed ID: 17706609
    [Abstract] [Full Text] [Related]

  • 5. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys.
    Buccafusco JJ, Weiser T, Winter K, Klinder K, Terry AV.
    Neuropharmacology; 2004 Jan 15; 46(1):10-22. PubMed ID: 14654093
    [Abstract] [Full Text] [Related]

  • 6. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
    Decker MW, Bannon AW, Curzon P, Gunther KL, Brioni JD, Holladay MW, Lin NH, Li Y, Daanen JF, Buccafusco JJ, Prendergast MA, Jackson WJ, Arneric SP.
    J Pharmacol Exp Ther; 1997 Oct 15; 283(1):247-58. PubMed ID: 9336330
    [Abstract] [Full Text] [Related]

  • 7. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
    Terry AV, Buccafusco JJ, Borsini F, Leusch A.
    Psychopharmacology (Berl); 2002 Jul 15; 162(3):292-300. PubMed ID: 12122487
    [Abstract] [Full Text] [Related]

  • 8. Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys.
    Terry AV, Plagenhoef M, Callahan PM.
    Psychopharmacology (Berl); 2016 Mar 15; 233(5):761-71. PubMed ID: 26612616
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys.
    Buccafusco JJ, Jackson WJ.
    Neurobiol Aging; 1991 Mar 15; 12(3):233-8. PubMed ID: 1876228
    [Abstract] [Full Text] [Related]

  • 10. Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys.
    Buccafusco JJ, Jackson WJ, Jonnala RR, Terry AV.
    Behav Pharmacol; 1999 Nov 15; 10(6-7):681-90. PubMed ID: 10780510
    [Abstract] [Full Text] [Related]

  • 11. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJ, Giardina WJ, Wasicak JT.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):319-28. PubMed ID: 7913497
    [Abstract] [Full Text] [Related]

  • 12. Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist.
    Damaj MI, Creasy KR, Welch SP, Rosecrans JA, Aceto MD, Martin BR.
    Psychopharmacology (Berl); 1995 Aug 15; 120(4):483-90. PubMed ID: 8539331
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats.
    McGaughy J, Decker MW, Sarter M.
    Psychopharmacology (Berl); 1999 May 15; 144(2):175-82. PubMed ID: 10394999
    [Abstract] [Full Text] [Related]

  • 14. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease.
    Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse PA.
    Psychopharmacology (Berl); 1999 Mar 15; 142(4):334-42. PubMed ID: 10229057
    [Abstract] [Full Text] [Related]

  • 15. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 16. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys.
    Terry AV, Risbrough VB, Buccafusco JJ, Menzaghi F.
    J Pharmacol Exp Ther; 2002 Apr 15; 301(1):284-92. PubMed ID: 11907185
    [Abstract] [Full Text] [Related]

  • 17. Velnacrine maleate improves delayed matching performance by aged monkeys.
    Jackson WJ, Buccafusco JJ, Terry AV, Turk DJ, Rush DK.
    Psychopharmacology (Berl); 1995 Jun 15; 119(4):391-8. PubMed ID: 7480518
    [Abstract] [Full Text] [Related]

  • 18. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    Brioni JD, O'Neill AB, Kim DJ, Buckley MJ, Decker MW, Arneric SP.
    J Pharmacol Exp Ther; 1994 Oct 15; 271(1):353-61. PubMed ID: 7965735
    [Abstract] [Full Text] [Related]

  • 19. The enhancement of contextual fear conditioning by ABT-418.
    Kenney JW, Wilkinson DS, Gould TJ.
    Behav Pharmacol; 2010 May 15; 21(3):246-9. PubMed ID: 20400893
    [Abstract] [Full Text] [Related]

  • 20. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder.
    Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Polisner D.
    Am J Psychiatry; 1999 Dec 15; 156(12):1931-7. PubMed ID: 10588407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.